1085 related articles for article (PubMed ID: 28341421)
41. The mutation matrix and the evolution of evolvability.
Jones AG; Arnold SJ; Bürger R
Evolution; 2007 Apr; 61(4):727-45. PubMed ID: 17439608
[TBL] [Abstract][Full Text] [Related]
42. The sculpting of somatic mutational landscapes by evolutionary forces and their impacts on aging-related disease.
Marongiu F; DeGregori J
Mol Oncol; 2022 Sep; 16(18):3238-3258. PubMed ID: 35726685
[TBL] [Abstract][Full Text] [Related]
43. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
44. Somatic stem cells and the origin of cancer.
Martínez-Climent JA; Andreu EJ; Prosper F
Clin Transl Oncol; 2006 Sep; 8(9):647-63. PubMed ID: 17005467
[TBL] [Abstract][Full Text] [Related]
45. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
46. Phenotypic Switching Can Speed up Microbial Evolution.
Tadrowski AC; Evans MR; Waclaw B
Sci Rep; 2018 Jun; 8(1):8941. PubMed ID: 29895935
[TBL] [Abstract][Full Text] [Related]
47. The origins, determinants, and consequences of human mutations.
Shendure J; Akey JM
Science; 2015 Sep; 349(6255):1478-83. PubMed ID: 26404824
[TBL] [Abstract][Full Text] [Related]
48. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
49. The guardians of inherited oncogenic vulnerabilities.
Arnal A; Tissot T; Ujvari B; Nunney L; Solary E; Laplane L; Bonhomme F; Vittecoq M; Tasiemski A; Renaud F; Pujol P; Roche B; Thomas F
Evolution; 2016 Jan; 70(1):1-6. PubMed ID: 26519218
[TBL] [Abstract][Full Text] [Related]
50. Modeling somatic evolution in tumorigenesis.
Spencer SL; Gerety RA; Pienta KJ; Forrest S
PLoS Comput Biol; 2006 Aug; 2(8):e108. PubMed ID: 16933983
[TBL] [Abstract][Full Text] [Related]
51. An evolutionary perspective on the systems of adaptive immunity.
Müller V; de Boer RJ; Bonhoeffer S; Szathmáry E
Biol Rev Camb Philos Soc; 2018 Feb; 93(1):505-528. PubMed ID: 28745003
[TBL] [Abstract][Full Text] [Related]
52. Metabolism and its sequelae in cancer evolution and therapy.
Gillies RJ; Gatenby RA
Cancer J; 2015; 21(2):88-96. PubMed ID: 25815848
[TBL] [Abstract][Full Text] [Related]
53. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.
Mo D; Zhao Y; Balajee AS
Cancer Lett; 2018 Jan; 413():1-10. PubMed ID: 29080750
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of oncogenic cell competition-Paths of victory.
Gutiérrez-Martínez A; Sew WQG; Molano-Fernández M; Carretero-Junquera M; Herranz H
Semin Cancer Biol; 2020 Jun; 63():27-35. PubMed ID: 31128299
[TBL] [Abstract][Full Text] [Related]
55. Characterization of stem cells and cancer cells on the basis of gene expression profile stability, plasticity, and robustness: dynamical systems theory of gene expressions under cell-cell interaction explains mutational robustness of differentiated cells and suggests how cancer cells emerge.
Kaneko K
Bioessays; 2011 Jun; 33(6):403-13. PubMed ID: 21538414
[TBL] [Abstract][Full Text] [Related]
56. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
[TBL] [Abstract][Full Text] [Related]
57. Characterizing the ecological and evolutionary dynamics of cancer.
Zahir N; Sun R; Gallahan D; Gatenby RA; Curtis C
Nat Genet; 2020 Aug; 52(8):759-767. PubMed ID: 32719518
[TBL] [Abstract][Full Text] [Related]
58. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.
Messerschmidt JL; Bhattacharya P; Messerschmidt GL
Curr Oncol Rep; 2017 Aug; 19(10):66. PubMed ID: 28803390
[TBL] [Abstract][Full Text] [Related]
59. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
60. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
